Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?
Soytas M, Dragomir A, Sawaya GB, Hesswani C, Tanguay M, Finelli A, Wood L, Rendon R, Bansal R, Lalani AK, Heng DYC, Bhindi B, Basappa NS, Dean L, So A, Nayak JG, Bjarnason G, Breau R, Lavallee L, Lattouf JB, Pouliot F, Bonert M, Tanguay S. Soytas M, et al. Among authors: bhindi b. BJU Int. 2024 Dec 4. doi: 10.1111/bju.16609. Online ahead of print. BJU Int. 2024. PMID: 39631366
Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality.
Robert A, Mallick R, McIsaac DI, Lavallée LT, Bhindi B, Heng D, Wood LA, Rendon R, Tanguay S, Finelli A, Bansal RK, Lalani AK, Basappa N, Mannas MP, Nayak JG, Bjarnason GA, Lattouf JB, Pouliot F, Richard PO, Tajzler C, Breau RH. Robert A, et al. Among authors: bhindi b. J Urol. 2024 Dec 2:101097JU0000000000004348. doi: 10.1097/JU.0000000000004348. Online ahead of print. J Urol. 2024. PMID: 39622017
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Graham J, Ahmad AE, Basappa NS, Bernhard JC, Bhindi B, Bossé D, Breau RH, Canil CM, Castonguay V, Finelli A, Heng DYC, Inman BA, Kollmannsberger C, Lalani AA, Lavallée LT, Msaouel P, Prendeville S, Soleimani M, Tanguay S, Wood L, Richard PO. Graham J, et al. Among authors: bhindi b. Can Urol Assoc J. 2024 Nov;18(11):E371-E386. doi: 10.5489/cuaj.9041. Can Urol Assoc J. 2024. PMID: 39500366 Free PMC article. No abstract available.
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.
Park CL, Moria FA, Ghosh S, Wood L, Bjarnason GA, Bhindi B, Heng DYC, Castonguay V, Pouliot F, Kollmannsberger CK, Bosse D, Basappa NS, Finelli A, Fallah-Rad N, Breau RH, Lalani AA, Tanguay S, Graham J, Saleh RR. Park CL, et al. Among authors: bhindi b. Curr Oncol. 2024 Aug 18;31(8):4704-4712. doi: 10.3390/curroncol31080351. Curr Oncol. 2024. PMID: 39195334 Free PMC article.
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Graham J, Ghosh S, Breau RH, Wood L, Tanguay S, Bosse D, Lalani AK, Bhindi B, Heng D, Finelli A, Fallah-Rad N, Castonguay V, Basappa NS, Soulières D, Pouliot F, Kollmannsberger C, Bjarnason GA. Graham J, et al. Among authors: bhindi b. Clin Genitourin Cancer. 2024 Jun;22(3):102060. doi: 10.1016/j.clgc.2024.02.011. Epub 2024 Feb 23. Clin Genitourin Cancer. 2024. PMID: 38521648
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Sawaya GB, Dragomir A, Wood LA, Kollmannsberger C, Basappa NS, Kapoor A, Soulières D, Finelli A, Heng DYC, Castonguay V, Canil C, Winquist E, Graham J, Bjarnason GA, Bhindi B, Lalani AK, Pouliot F, Breau RH, Saleh R, Tanguay S. Sawaya GB, et al. Among authors: bhindi b. Eur Urol Oncol. 2024 Jun;7(3):570-580. doi: 10.1016/j.euo.2023.11.016. Epub 2023 Dec 13. Eur Urol Oncol. 2024. PMID: 38097481
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System.
Cardenas LM, Ghosh S, Finelli A, Wood L, Kollmannsberger C, Basappa N, Graham J, Heng D, Bjarnason G, Soulières D, Bossé D, Castonguay V, Saleh R, Tanguay S, Bhindi B, Breau RH, Pouliot F, Lalani AA. Cardenas LM, et al. Among authors: bhindi b. JCO Glob Oncol. 2023 Sep;9:e2300271. doi: 10.1200/GO.23.00271. JCO Glob Oncol. 2023. PMID: 37992270 Free PMC article.
108 results